Answers are grounded in this paper and cite their sources.
Retrospective study reveals high treatment costs among inpatients with peptic ulcer disease, indicating that reducing hospital stays and optimizing supply usage could lower economic burdens.
Peptic ulcer disease (PUD) imposes a substantial economic burden due to prolonged hospitalization and severe complications. This study evaluated the direct medical costs of inpatient PUD treatment from the healthcare provider perspective in Vietnam. A retrospective study was conducted using the electronic medical records of 1,985 inpatients diagnosed with PUD at a military hospital between 2017 and 2022. Direct medical costs during hospitalization were analyzed using Microsoft Excel 2019 and SPSS version 26.0. The total inpatient treatment cost for PUD during the study period was USD 4,142,121, with a mean cost of USD 2,086.7 per patient. Medication costs amounted to USD 88,640, of which proton pump inhibitors represented the largest proportion (USD 80,350). Medical supplies and prolonged hospitalization were the major contributors to overall expenditures. PUD creates a considerable financial burden on both patients and the healthcare system in Vietnam. Strategies aimed at reducing hospitalization duration and optimizing resource utilization may help decrease treatment costs and improve healthcare efficiency.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: